Regulus Therapeutics Inc. (RGLS) Common Stock, Shares, Outstanding 2011 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Regulus Therapeutics Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from 2011 to 2024.
  • Regulus Therapeutics Inc. Common Stock, Shares, Outstanding for the quarter ending March 31, 2024 was 65.5 M shares, a 288% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 65.5 M +48.6 M +288% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 20.2 M +3.38 M +20.1% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 20.2 M +3.38 M +20.1% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 19.5 M +4.85 M +33.1% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 16.9 M -129 M -88.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 16.8 M +2.24 M +15.4% Dec 31, 2022 10-K 2024-03-21
Q3 2022 16.8 M -70.2 M -80.7% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 14.6 M -72.4 M -83.2% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 146 M +71.3 M +95.5% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 14.6 M -52.8 M -78.4% Dec 31, 2021 10-K 2023-03-23
Q3 2021 87 M +47.9 M +122% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 87 M +51.1 M +142% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 74.7 M +47.1 M +171% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 67.4 M +46.4 M +221% Dec 31, 2020 10-K 2022-03-11
Q3 2020 39.2 M +18.2 M +87.1% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 35.9 M +15.1 M +72.5% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 27.6 M +16.8 M +155% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 21 M +12.2 M +138% Dec 31, 2019 10-K 2021-03-09
Q3 2019 20.9 M +12.2 M +139% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 20.8 M -83.6 M -80.1% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 10.8 M -93.5 M -89.6% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 8.82 M +156 K +1.8% Dec 31, 2018 10-K 2020-03-12
Q3 2018 8.75 M -95.2 M -91.6% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 104 M +51.2 M +96.4% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 104 M +51.1 M +96.2% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 8.66 M -44.3 M -83.6% Dec 31, 2017 10-K 2019-03-18
Q3 2017 104 M +51 M +96.4% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 53.2 M +395 K +0.75% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 53.2 M +408 K +0.77% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 52.9 M +256 K +0.49% Dec 31, 2016 10-K 2018-03-08
Q3 2016 52.9 M +581 K +1.11% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 52.8 M +1.25 M +2.43% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 52.8 M +2.01 M +3.96% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 52.7 M +3.72 M +7.61% Dec 31, 2015 10-K 2017-03-03
Q3 2015 52.3 M +8.9 M +20.5% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 51.5 M +8.15 M +18.8% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 50.8 M +7.42 M +17.1% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 48.9 M +7.16 M +17.1% Dec 31, 2014 10-K 2016-02-23
Q3 2014 43.4 M +1.67 M +3.99% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 43.4 M +7.3 M +20.2% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 43.3 M +7.38 M +20.5% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 41.8 M +5.96 M +16.6% Dec 31, 2013 10-K 2015-02-19
Q3 2013 41.8 M +41.6 M +27171% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 36.1 M Jun 30, 2013 10-Q/A 2013-08-16
Q1 2013 36 M Mar 31, 2013 10-Q 2013-05-15
Q4 2012 35.8 M +35.7 M +23291% Dec 31, 2012 10-K 2014-02-28
Q3 2012 153 K Sep 30, 2012 10-Q 2012-11-19
Q4 2011 153 K Dec 31, 2011 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.